Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.
An Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycophenolate for the Management of Newly Diagnosed Immune Thrombocytopenia Purpura: a Cost Effective Measure in Developing Nations.
Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Listed as NCT06288932, this PHASE3 trial focuses on Immune Thrombocytopenia Purpura and remains completed. Sponsored by National Institute of Blood and Marrow Transplant (NIBMT), Pakistan, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Dec 2024 — Present [monthly]
Completed PHASE3
-
Nov 2024 — Dec 2024 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
▶ Show 1 earlier version
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
First recorded
Aug 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
For direct contact, visit the study record on ClinicalTrials.gov .